What is RNTX's dilution risk score?

RNTX has a latest available DilutionScore record of 48/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for RNTX, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for RNTX?

DilutionWatch tracks 25 SEC filing types for RNTX including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect RNTX shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For RNTX, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for RNTX tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for RNTX. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

RNTX Dilution Risk Score: 48/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

100

💰 Cash Runway

10

📊 Float Risk

2

⚠️ Warrant Exposure

40

🔄 Convertible Debt

40

Dilution Forecast

⛅

Watch

Minor dilution signals detected

model est. 28%

💰 Capital Raise model 38%

• Active shelf registration ($498M, 524% of market cap)

• Active ATM program with $8M remaining capacity

🔄 Reverse Split model est. 30%

• 50-day avg $1.32 approaching $1 threshold

🔔 Track RNTX — Get forecast alerts →

Market Data

Market Cap$94.95M

Shares Outstanding86.27M

Float71.50M

Cash$40.65M

Debt$4.92M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.1% shares (2026Q1 vs prior)

46 institutional holders · 12.40M shares

#1 Voss Capital, LP 4.39M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 2.00M shares

#3 BIOS Capital Management, LP 1.98M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest875.0K

Days to Cover1.9

% of Float1.2%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30

xbrl XBRL CONVERTIBLE 2024-12-31

424B5 ATM 2026-05-04

EFFECT EFFECT 2026-04-30

S-1 SHELF 2026-04-28

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual RNTX Dilution Snapshot

Rein Therapeutics Inc. (RNTX) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: August 28, 2026.

Stored shelf registration capacity: $498.0M.
Stored ATM program remaining capacity: $8.1M.
Recent SEC activity tracked for RNTX: xbrl on 2026-06-30; 424B5 on 2026-05-04; EFFECT on 2026-04-30.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.